Literature DB >> 21521549

DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging.

David M Yurek, Anita M Fletcher, Matthew McShane, Tomasz H Kowalczyk, Linas Padegimas, Marcy R Weatherspoon, Michael D Kaytor, Mark J Cooper, Assem G Ziady.   

Abstract

In this study, we used bioluminescence imaging (BLI) to track long-term transgene activity following the transfection of brain cells using a nonviral gene therapy technique. Formulations of deoxyribonucleic acid (DNA) combined with 30-mer lysine polymers (substituted with 10 kDa polyethylene glycol) form nanoparticles that transfect brain cells in vivo and produce transgene activity. Here we show that a single intracerebral injection of these DNA nanoparticles (DNPs) into the rat cortex, striatum, or substantia nigra results in long-term and persistent luciferase transgene activity over an 8- to 11-week period as evaluated by in vivo BLI analysis, and single injections of DNPs into the mouse striatum showed stable luciferase transgene activity for 1 year. Compacted DNPs produced in vivo signals 7- to 34-fold higher than DNA alone. In contrast, ex vivo BLI analysis, which is subject to less signal quenching from surrounding tissues, demonstrated a DNP to DNA alone ratio of 76- to 280-fold. Moreover, the ex vivo BLI analysis confirmed that signals originated from the targeted brain structures. In summary, BLI permits serial analysis of luciferase transgene activity at multiple brain locations following gene transfer with DNPs. Ex vivo analysis may permit more accurate determination of relative activities of gene transfer vectors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521549      PMCID: PMC3173525          DOI: 10.2310/7290.2010.00053

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  21 in total

Review 1.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Authors:  Tarik F Massoud; Sanjiv S Gambhir
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

2.  Nanoparticles of compacted DNA transfect postmitotic cells.

Authors:  Ge Liu; DeShan Li; Murali K Pasumarthy; Tomasz H Kowalczyk; Christopher R Gedeon; Susannah L Hyatt; Jennifer M Payne; Timothy J Miller; Peter Brunovskis; Tamara L Fink; Osman Muhammad; Robert C Moen; Richard W Hanson; Mark J Cooper
Journal:  J Biol Chem       Date:  2003-06-14       Impact factor: 5.157

3.  Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging.

Authors:  A Rehemtulla; L D Stegman; S J Cardozo; S Gupta; D E Hall; C H Contag; B D Ross
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

4.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

Authors:  C Plank; K Mechtler; F C Szoka; E Wagner
Journal:  Hum Gene Ther       Date:  1996-08-01       Impact factor: 5.695

5.  Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.

Authors:  Assem-Galal Ziady; Christopher R Gedeon; Timothy Miller; William Quan; Jennifer M Payne; Susannah L Hyatt; Tamara L Fink; Osman Muhammad; Sharon Oette; Tomasz Kowalczyk; Murali K Pasumarthy; Robert C Moen; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

6.  Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung.

Authors:  Assem-Galal Ziady; Christopher R Gedeon; Osman Muhammad; Virginia Stillwell; Sharon M Oette; Tamara L Fink; Will Quan; Tomasz H Kowalczyk; Susannah L Hyatt; Jennifer Payne; Angela Peischl; J E Seng; Robert C Moen; Mark J Cooper; Pamela B Davis
Journal:  Mol Ther       Date:  2003-12       Impact factor: 11.454

7.  Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.

Authors:  David M Yurek; Anita M Flectcher; Tomasz H Kowalczyk; Linas Padegimas; Mark J Cooper
Journal:  Cell Transplant       Date:  2009-06-22       Impact factor: 4.064

8.  Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice.

Authors:  J S Burgos; M Rosol; R A Moats; V Khankaldyyan; D B Kohn; M D Nelson; W E Laug
Journal:  Biotechniques       Date:  2003-06       Impact factor: 1.993

9.  In vivo tracking of neural progenitor cell migration to glioblastomas.

Authors:  Yi Tang; Khalid Shah; Shanta M Messerli; Evan Snyder; Xandra Breakefield; Ralph Weissleder
Journal:  Hum Gene Ther       Date:  2003-09-01       Impact factor: 5.695

10.  Imaging of stem cell recruitment to ischemic infarcts in a murine model.

Authors:  Dong-Eog Kim; Dawid Schellingerhout; Ken Ishii; Khalid Shah; Ralph Weissleder
Journal:  Stroke       Date:  2004-02-26       Impact factor: 7.914

View more
  16 in total

1.  Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

Authors:  A M Fletcher; T H Kowalczyk; L Padegimas; M J Cooper; D M Yurek
Journal:  Neuroscience       Date:  2011-08-04       Impact factor: 3.590

2.  Optimization of hCFTR lung expression in mice using DNA nanoparticles.

Authors:  Linas Padegimas; Tomasz H Kowalczyk; Sam Adams; Chris R Gedeon; Sharon M Oette; Karla Dines; Susannah L Hyatt; Ozge Sesenoglu-Laird; Olena Tyr; Robert C Moen; Mark J Cooper
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

3.  Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.

Authors:  Brian P Mead; Namho Kim; G Wilson Miller; David Hodges; Panagiotis Mastorakos; Alexander L Klibanov; James W Mandell; Jay Hirsh; Jung Soo Suk; Justin Hanes; Richard J Price
Journal:  Nano Lett       Date:  2017-05-18       Impact factor: 11.189

4.  Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

Authors:  Rheal A Towner; David L Gillespie; Andrea Schwager; Debra G Saunders; Nataliya Smith; Charity E Njoku; Richard S Krysiak; Chelsea Larabee; Henna Iqbal; Robert A Floyd; David W A Bourne; Osama Abdullah; Edward W Hsu; Randy L Jensen
Journal:  Neuro Oncol       Date:  2013-01-17       Impact factor: 12.300

5.  S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.

Authors:  Adarsha Koirala; Rasha S Makkia; Shannon M Conley; Mark J Cooper; Muna I Naash
Journal:  Hum Mol Genet       Date:  2013-01-18       Impact factor: 6.150

6.  Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease.

Authors:  Amirah E-E Aly; Brendan T Harmon; Linas Padegimas; Ozge Sesenoglu-Laird; Mark J Cooper; Barbara L Waszczak
Journal:  Mol Neurobiol       Date:  2018-05-19       Impact factor: 5.590

7.  Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases.

Authors:  Adarsha Koirala; Shannon M Conley; Rasha Makkia; Zhao Liu; Mark J Cooper; Janet R Sparrow; Muna I Naash
Journal:  J Control Release       Date:  2013-09-11       Impact factor: 9.776

8.  Designing DNA nanodevices for compatibility with the immune system of higher organisms.

Authors:  Sunaina Surana; Avinash R Shenoy; Yamuna Krishnan
Journal:  Nat Nanotechnol       Date:  2015-09       Impact factor: 39.213

9.  Highly compacted pH-responsive DNA nanoparticles mediate transgene silencing in experimental glioma.

Authors:  Anthony J Kim; Graeme F Woodworth; Nicholas J Boylan; Jung Soo Suk; Justin Hanes
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

Review 10.  Stimuli Responsive, Programmable DNA Nanodevices for Biomedical Applications.

Authors:  Udisha Singh; Vinod Morya; Bhaskar Datta; Chinmay Ghoroi; Dhiraj Bhatia
Journal:  Front Chem       Date:  2021-06-30       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.